Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital
Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital
Tonix Pharmicals 已在马萨诸塞州综合医院招收了第一位参与者 TNX-1900(鼻内增强催产素)治疗儿科肥胖症的 “POWER” 第二阶段 “POWER” 研究
Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital
Tonix Pharmicals 已在马萨诸塞州综合医院招收了第一位参与者 TNX-1900(鼻内增强催产素)治疗儿科肥胖症的 “POWER” 第二阶段 “POWER” 研究